drugset / Trial / NCT01855243

Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DM

NCT01855243

Completed 63 enrolled Cairo University
RandomizedParallel-groupOpen-labelTreatment

Summary

Purpose: To compare efficacy and safety of traditional sliding scale insulin (SSI) versus modified 70/30 insulin versus modified basal plus supplemental scale /bolus insulin regimens for glycemic control in hospitalized diabetic patients with diabetes. Methods: In a prospective trial, patients with diabetes will be randomized to receive either traditional hospital SSI , or twice daily 70/30 insulin plus supplemental lunchtime insulin for BG ≥ 150 mg/dL or once every night glargine plus three times prandial glulisine for BG ≥ 150 mg/dL . 70/30 insulin and glargine will be started respectively at 0.4 and 0.2 U/kg/day for BG ≤ 200 mg/dL or 0.5 and 0.3 U/kg/day for BG above 200 mg/dL.

Timeline

Start
2010-03
Primary completion
2014-02
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator 70/30 insulin Unknown 0.4 iu/kg
Comparator 70/30 insulin Unknown 0.5 iu/kg
Comparator Insulin Protein / enzyme biologic Subcutaneous
Comparator Insulin glulisine Protein / enzyme biologic
Comparator insulin glargine Protein / enzyme biologic 0.2 iu/kg
Comparator insulin glargine Protein / enzyme biologic 0.3 iu/kg